Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.

MLA

Simpson, Eric L., et al. “Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.” Dermatology & Therapy, vol. 14, no. 1, Jan. 2024, pp. 261–70. EBSCOhost, https://doi.org/10.1007/s13555-023-01061-4.

APA

Simpson, E. L., Lockshin, B., Lee, L. W., Chen, Z., Daoud, M., & Korotzer, A. (2024). Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology & Therapy, 14(1), 261–270. https://doi.org/10.1007/s13555-023-01061-4

Chicago

Simpson, Eric L., Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, and Andrew Korotzer. 2024. “Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.” Dermatology & Therapy 14 (1): 261–70. doi:10.1007/s13555-023-01061-4.